Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-18

Clinical Trial Update: Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the safety and efficacy of rasagiline in patients with amyotrophic lateral sclerosis. The study has completed and results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azilect (rasagiline)

Snippet

Sponsor: Yunxia Wang, MD | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: COMPLETED | Results posted: 2018-05-18